Beit Oved, Israel

Roman Kleinerman


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Beit Oved, IL (2016)
  • Netaim, IL (2016)

Company Filing History:


Years Active: 2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Roman Kleinerman: Innovator in Optical Network Technologies

Introduction

Roman Kleinerman is a notable inventor based in Beit Oved, Israel. He has made significant contributions to the field of optical network technologies, holding 2 patents that showcase his innovative approach to power management and communication systems.

Latest Patents

Kleinerman's latest patents include "Systems and methods for advanced power management for optical network terminal systems on chip." This invention provides systems for customer premises equipment (CPE) on a passive optical network (PON). The system features a packet processor that operates in both active and sleep modes, efficiently managing data streams from an optical line terminal (OLT). Additionally, he has developed a "Passive optical network switch," which regenerates optical communication signals compliant with PON protocols, facilitating communication between an Optical Line Terminal (OLT) and an Optical Network Unit (ONU).

Career Highlights

Roman Kleinerman is currently employed at Marvell World Trade Ltd., where he continues to innovate in the field of optical networks. His work focuses on enhancing the efficiency and functionality of communication systems, contributing to advancements in technology.

Collaborations

Kleinerman collaborates with talented individuals such as Dimitry Melts and Israel Ben-Shahar, who share his passion for innovation and technology.

Conclusion

Roman Kleinerman's contributions to optical network technologies reflect his dedication to innovation and excellence. His patents demonstrate a commitment to improving communication systems, making a lasting impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…